Skip to main content

Table 1 Tumor and patient characteristics (n = 53)

From: EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: Implications for targeted radiotherapy

Characteristics

Patients, n (%)

Differentiation

 

   High

5 (9.4)

   Moderate

42 (79.3)

   Low

6 (11.3)

FIGO Stage

 

   IB

16 (30.2)

   IIA

35 (66.0)

   IIB

1 (1.9)

   IIIB

1 (1.9)

Tumor size

 

   > 5 cm

9 (17.0)

   3–5 cm

26 (49.0)

   < 3 cm

18 (34.0)

Lymphatic or vascular space invasion

 

   Positive

26 (49.1)

   Negative

27 (50.9)

Vaginal invasion

 

   Positive

37 (69.8)

   Negative

16 (30.2)

Parametrial invasion

 

   Positive

6 (11.3)

   Negative

47 (88.7)

Age (years)

 

   Medium

48

   Range

29–72